Skip to content
Home/Companies/Biotech/GutCRINE

GutCRINE

Biotech·Denmark·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns GutCRINE?

GutCRINE is a Danish Biotech company, currently owned by Eir Ventures since 2023 and UCPH Ventures.

Hand-verified · updated 2026-08-17

Open JSON · CC-BY
UCPH Ventures
Most recent investor
UCPH Ventures
UCPH Ventures · 2022 · VC
2 ownership periods · full history below

Key facts

HQDenmark
SectorBiotech
StatusActive

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by Eir Ventures and UCPH Ventures since 2023.
Co-invest · 2 holders · 2023 · present
Eir Ventures
Eir VenturesActive
2023 · present(3yr) · Eir Ventures I · 2020 · Life Sciences VC
UCPH Ventures
UCPH VenturesActive
2023 · present(3yr) · UCPH Ventures · 2022 · VC

More from UCPH Ventures

Other portfolio companies in the same fund.

Dania Therapeutics
Active
BiotechDenmark· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns GutCRINE?

GutCRINE is currently owned by Eir Ventures and UCPH Ventures, through UCPH Ventures, since 2023.

When did Eir Ventures and 1 other acquire GutCRINE?

Eir Ventures and 1 other acquired GutCRINE in 2023.

Who has owned GutCRINE over time?

GutCRINE has been through 2 private-equity ownership periods: Eir Ventures · via Eir Ventures I · since 2023; UCPH Ventures · via UCPH Ventures · since 2023.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue